Sitewide
MR spectroscopy identifies breast cancer, reduces biopsies
Proton magnetic resonance spectroscopy used in conjunction with magnetic resonance imaging can aid radiologists in diagnosing breast cancer while reducing the number of false-positive results and invasive biopsies, according to a study focusing on nonmass-enhancing breast lesions. The study, conducted at Memorial Sloan-Kettering Cancer Center in New York City, appears in the October issue of the journal Radiology.
Similar Articles On This Topic:
- Jefferson researchers identify possible imaging method to stratify breast cancer without biopsy
- Elastography reduces unnecessary breast biopsies
- Targeted breast ultrasound can reduce biopsies for women under 40
- Noninvasive combination technique may reduce number of breast biopsies
- New statistical model could help reduce breast-lesion biopsies
Popular Today:
Science 2.0:
Recent Articles:
Read Us On Your Kindle:
Create Your Own Releases:
Post new comment